Long noncoding RNA GAPLINC promotes invasion in colorectal cancer by targeting SNAI2 through binding with PSF and NONO
Metrics: PDF 1681 views | HTML 1638 views | ?
Peng Yang1,*, Tao Chen1,*, Zipeng Xu1, Hua Zhu2, Jie Wang2, Zhenyu He1,2
1The Second Clinical Medical College of Nanjing Medical University, Nanjing, China
2Department of General Surgery, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China
*These authors have contributed equally to this work
Zhenyu He, email: firstname.lastname@example.org
Keywords: colorectal cancer, GAPLINC, long noncoding RNA, NONO, PSF
Received: March 18, 2016 Accepted: May 13, 2016 Published: May 31, 2016
This study aimed to investigate the role of long noncoding RNAs (lncRNAs) in the metastasis of colorectal cancer (CRC). Metastasis is an important prognostic factor of CRC, and lncRNAs have been implicated in tumor proliferation and metastasis. The human CRC cell lines HCT116, HT29, SW480, DLD-1, and SW620 were used in the study. Genome-wide lncRNA expression patterns in metastatic lymph nodes compared with paired normal lymph nodes of CRC were assessed by microarray analysis. Gastric adenocarcinoma predictive long intergenic noncoding (GAPLINC) RNA was detected via functional prediction. The increased expression of GAPLINC was found to be positively correlated with larger tumor size, advanced tumor stage (T stage), advanced node stage (N stage), increased death, and shorter survival of patients with CRC by in situ hybridization analysis. Besides, the decreased expression of GAPLINC could significantly repress CRC cell invasion in vitro and also inhibit proliferation in vitro and in vivo. RNA pull-down with mass spectrum experiments revealed that PTB-associated splicing factor (PSF) and non-POU-domain-containing octamer-binding (NONO) protein bound to GAPLINC and reversed the effect of GAPLINC on cell invasion. Gene array and bioinformatics analyses identified that snail family zinc finger 2 (SNAI2) was involved in the biological processes of GAPLINC/PSF/NONO. This study indicated the importance of GAPLINC in promoting CRC invasion via binding to PSF/NONO and partly by stimulating the expression of SNAI2. Hence, GAPLINC may serve as a promising target for CRC diagnosis and therapy. The findings may help in developing a novel therapeutic strategy for patients with CRC.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.